GB1409936A - Prostaglandin-type compounds - Google Patents

Prostaglandin-type compounds

Info

Publication number
GB1409936A
GB1409936A GB5453373A GB5453373A GB1409936A GB 1409936 A GB1409936 A GB 1409936A GB 5453373 A GB5453373 A GB 5453373A GB 5453373 A GB5453373 A GB 5453373A GB 1409936 A GB1409936 A GB 1409936A
Authority
GB
United Kingdom
Prior art keywords
formula
compound
nov
alkyl
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5453373A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1409936A publication Critical patent/GB1409936A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)

Abstract

1409936 Prostaglandins ROUSSEL UCLAF 23 Nov 1973 [23 Nov 1972] 54533/73 Heading C2C Novel compounds of Formula I (in which R=H or C 1-4 alkyl, R 1 = H or C 1-2 alkyl, R 2 = H or α-tetrahydropyranyl, m = 3, 4 or 5 and n=2, 3 or 4) and the base salts of those compounds in which R = H, are prepared by reacting a compound of Formula II with a compound of formula and, if desired, converting a resulting compound I in which R = H into a base salt. Pharmaceutical compositions having hypotensive, smooth muscle contracting, antibron - choconstrictive and antilipolytic activity, for oral, parenteral, rectal or topical administration, comprise one of the above novel compounds together with one or more pharmaceutical carriers or excipients. The compositions may also be in an aerosol form.
GB5453373A 1972-11-23 1973-11-23 Prostaglandin-type compounds Expired GB1409936A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7241604A FR2207701B1 (en) 1972-11-23 1972-11-23

Publications (1)

Publication Number Publication Date
GB1409936A true GB1409936A (en) 1975-10-15

Family

ID=9107575

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5453373A Expired GB1409936A (en) 1972-11-23 1973-11-23 Prostaglandin-type compounds

Country Status (9)

Country Link
JP (1) JPS49100062A (en)
BE (1) BE807668A (en)
CA (1) CA1018971A (en)
CH (1) CH581100A5 (en)
DE (1) DE2358420A1 (en)
FR (1) FR2207701B1 (en)
GB (1) GB1409936A (en)
IE (1) IE38536B1 (en)
NL (1) NL7316086A (en)

Also Published As

Publication number Publication date
FR2207701A1 (en) 1974-06-21
FR2207701B1 (en) 1975-11-28
BE807668A (en) 1974-05-22
IE38536B1 (en) 1978-04-12
NL7316086A (en) 1974-05-27
CA1018971A (en) 1977-10-11
DE2358420A1 (en) 1974-05-30
CH581100A5 (en) 1976-10-29
IE38536L (en) 1974-05-23
JPS49100062A (en) 1974-09-20

Similar Documents

Publication Publication Date Title
GB1301973A (en)
GB1439724A (en) Berbine derivatives and pharmaceutical compositions containing them
GB1252329A (en)
ES450897A1 (en) N-Tetrahydrofurfuryl-noroxymorphones, their salts, and analgesic compositions and methods employing them
GB1530074A (en) Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents
GB1409648A (en) Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof
GB1394619A (en) Imides
GB1409936A (en) Prostaglandin-type compounds
IE36597L (en) Preparing a 1,2-dihydrophthalazine
GB1263116A (en) Chloramphenicol and thiamphenicol derivatives
GB1186495A (en) 0-[3-(4-Fluorobenzoyl) Proplyl]-4-Substituted Piperazines, their Acid Addition Salts and their method of preparation
GB1503447A (en) Dl-and 8r-9-fluoro-prostadienoic acid derivatives and process
GB1356937A (en) Pyrimido-isoquinolines
GB1393228A (en) 2-2-2-methyl-5-nitro-1-imidazolyl-ethyl-2-thiopseudoureas and related compounds
IE35223L (en) Bis-basic ethers of 2, 6- and 2, 7-dihydroxy-anthraquinones
GB1512930A (en) Substituted 4-hydroxybenzylidene malononitriles
GB1296431A (en)
GB1478262A (en) Prostadienoic acid derivatives
GB1322069A (en) Aminoalkanoylaminocyclohexane derivatives
ES360153A1 (en) Procedure for the preparation of bencilideno-amido-hidracinas. (Machine-translation by Google Translate, not legally binding)
GB1527941A (en) 1-(3-phenylpropyl)-4-(beta-alkoxyacryloyl)piperazine derivatives
GB1032268A (en) New guanyl-hydrazones and preparations containing them
GB1294825A (en)
GB1363640A (en) Esters of 2,2-diphenyl - cyclopropane - carboxylic acids
ES363742A1 (en) N-Substituted 2-Hydroxymorphinanes and Pharmaceutical Compositions containing them

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee